ArticleFrontiers in medicine2024
Early detection of Alzheimer's disease in structural and functional MRI.
Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms.Neural regeneration research · 2026Article
- Alzheimer's disease detection from structural brain MRI using FFA U-Net segmentation and transfer learning.Frontiers in neuroscience · 2026Article
- Integration of Neuroimaging and Molecular Biomarkers in the Diagnosis of Alzheimer's Disease and Frontotemporal Dementia: The Promise of fMRI.Current Alzheimer research · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To implement state-of-the-art deep learning architectures such as Deep-Residual-U-Net and DeepLabV3+ for precise segmentation of hippocampus and ventricles, in functional magnetic resonance imaging (fMRI). Integrate VGG-16 with Random Forest (VGG-16-RF) and VGG-16 with Support Vector Machine (VGG-16-SVM) to enhance the binary classification accuracy of Alzheimer's disease, comparing their performance against traditional classifiers. Method: OpenNeuro and Harvard's Data verse provides Alzheimer's coronal functional MRI data. Ventricles and hippocampus are segmented using a Deep-Residual-UNet and Deep labV3+ system. The functional features were extracted from each segmented component and classified using SVM, Adaboost, Logistic regression, and VGG 16, DenseNet-169, VGG-16-RF, and VGG-16-SVM classifier. Results: This research proposes a precise and efficient deep-learning architecture like DeepLab V3+ and Deep Residual U-NET for hippocampus and ventricle segmentation in detection of AD. DeepLab V3+ has produced a good segmentation accuracy of 94.62% with Jaccard co-efficient of 85.5% and dice co-efficient of 84.75%. Among the three ML classifiers used, SVM has provided a good accuracy of 93%. Among some DL techniques, VGG-16-RF classifier has given better accuracy of 96.87%. Conclusion: The novelty of this work lies in the seamless integration of advanced segmentation techniques with hybrid classifiers, offering a robust and scalable framework for early AD detection. The proposed study demonstrates a significant advancement in the early detection of Alzheimer's disease by integrating state-of-the-art deep learning models and comprehensive functional connectivity analysis. This early detection capability is crucial for timely intervention and better management of the disease in neurodegenerative disorder diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.